Question

I am a breastfeeding mother and i want to know if it is safe to use UNII-2XJX250C20? Is UNII-2XJX250C20 safe for nursing mother and child? Does UNII-2XJX250C20 extracts into breast milk? Does UNII-2XJX250C20 has any long term or short term side effects on infants? Can UNII-2XJX250C20 influence milk supply or can UNII-2XJX250C20 decrease milk supply in lactating mothers?

Answer by DrLact: About UNII-2XJX250C20 usage in lactation

No information is available on the clinical use of UNII-2XJX250C20 during breastfeeding. Because UNII-2XJX250C20 is 98% bound to plasma proteins, the amount in milk is likely to be low. However, because of its potential toxicity in the breastfed infant and its half-life of 70 hours, the manufacturer recommends that breastfeeding be discontinued during UNII-2XJX250C20 therapy and for at least 17 days after the last dose.

Alternate Drugs

Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Vincristine(Dangerous)
Rituximab(Low Risk)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Letrozole(Dangerous)
Docetaxel(Dangerous)
Exemestane(Dangerous)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Hydroxyurea(Low Risk)
Trastuzumab(Unsafe)
Etoposide(Dangerous)
Doxorubicin(Dangerous)
Erlotinib(Unsafe)
Cyclophosphamide(Dangerous)
Imatinib(Unsafe)
Cisplatin(Unsafe)
Dactinomycin(Dangerous)
Ipilimumab(Unsafe)
Busulfan(Dangerous)
Cetuximab(Unsafe)
Nivolumab(Unsafe)
Carboplatin(Dangerous)
Vinblastine(Dangerous)
Pazopanib(Unsafe)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Gemcitabine(Dangerous)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.